OTCMKTS:BNKL

Bionik Laboratories Stock Insider Trading

> Medical - Care Facilities

Buy BNKL

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 03, 2026

Bionik Laboratories Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 13.22M and sold 9.99K BNKL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	13.22M shares
● Sell	9.99K shares
98% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 06, 2023 Buy	Stock Option (Right to Buy)	Gonsalves Daniel Executive Vice President & CFO	CEO / President	60 000 Value: $18.1K
Oct 06, 2023 Buy	Stock Option (Right to Buy)	Gonsalves Daniel Executive Vice President & CFO	CEO / President	60 000 Value: $18.1K
Jun 13, 2023 Buy	Common Stock, par value $0.001 per share C-Conversion	Gaston-dreyfus Remi	Director	3 102 878 Value: $1.86M
Jun 13, 2023 Buy	Common Stock C-Conversion	Auberton-herve Andre-jacques Director	Director	186 111 Value: $111.7K
Jun 13, 2023 Buy	Convertible Promissory Note P-Purchase	Auberton-herve Andre-jacques Director	Director	1 Value: $1
Jun 13, 2023 Buy	Convertible Promissory Note P-Purchase	Auberton-herve Andre-jacques Director	Director	1 Value: $1
Jun 13, 2023 Buy	Common Stock C-Conversion	Auberton-herve Andre-jacques Director	Director	186 111 Value: $111.7K
Jun 13, 2023 Buy	Common Stock, par value $0.001 per share C-Conversion	Gaston-dreyfus Remi	Director	3 102 878 Value: $1.86M
Jun 09, 2023 Buy	Common Stock, par value $0.001 per share P-Purchase	Matine Charles Director	Director	180 555 Value: $108.3K
Jun 09, 2023 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi	Director	180 555 Value: $108.3K
Jun 09, 2023 Buy	Common Stock P-Purchase	Auberton-herve Andre-jacques Director	Director	650 000 Value: $390.0K
Jun 09, 2023 Buy	Common Stock P-Purchase	Auberton-herve Andre-jacques Director	Director	650 000 Value: $390.0K
Jun 09, 2023 Buy	Common Stock, par value $0.001 per share P-Purchase	Gaston-dreyfus Remi	Director	180 555 Value: $108.3K
Jun 09, 2023 Buy	Common Stock, par value $0.001 per share P-Purchase	Matine Charles Director	Director	180 555 Value: $108.3K
Oct 06, 2022 Buy	Employee Stock Option (right to buy) A-Award	Russo Richard Paul Jr CEO And President	CEO / President	60 000 Value: $0
Oct 06, 2022 Buy	Employee Stock Option (right to buy) A-Award	Russo Richard Paul Jr CEO And President	CEO / President	60 000 Value: $0
Mar 31, 2022 Buy	Common Stock, par value $0.001 per share C-Conversion	Gaston-dreyfus Remi	Director	77 887 Value: $739.9K
Mar 31, 2022 Buy	Common Stock, par value $0.001 per share C-Conversion	Gaston-dreyfus Remi	Director	77 887 Value: $739.9K
Nov 30, 2021 Buy	Stock Option (Right to Buy)	Russo Richard Paul Jr Chief Financial Officer	C-Suite Officer	76 902 Value: $93.1K
Nov 30, 2021 Buy	Stock Option (Right to Buy)	Russo Richard Paul Jr Chief Financial Officer	C-Suite Officer	76 902 Value: $93.1K
Oct 14, 2021 Buy	Employee Stock Option (right to buy) A-Award	Wass Loren W. See Remarks	Officer	55 000 Value: $115.5K
Oct 14, 2021 Buy	Employee Stock Option (right to buy) A-Award	Wass Loren W. See Remarks	Officer	55 000 Value: $115.5K
Oct 14, 2021 Buy	Employee Stock Option (right to buy) A-Award	Russo Richard Paul Jr CFO And Interim CEO	CEO / President	80 000 Value: $168.0K
Oct 14, 2021 Buy	Employee Stock Option (right to buy) A-Award	Russo Richard Paul Jr CFO And Interim CEO	CEO / President	80 000 Value: $168.0K
Jul 15, 2021 Buy	Common Stock, par value $0.001 per share M-Exempt	Auberton-herve Andre-jacques Director	Director	7 500 Value: $23.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BIONIK LABORATORIES CORP.

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy...

Read Full Profile Here